540788 — Aspira Pathlab & Diagnostics Income Statement
0.000.00%
Last trade - 00:00
- IN₹325.26m
- IN₹334.80m
- IN₹144.57m
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 76.4 | 84.2 | 152 | 195 | 145 |
Cost of Revenue | |||||
Gross Profit | 53.8 | 64.3 | 126 | 164 | 120 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 121 | 119 | 131 | 148 | 144 |
Operating Profit | -44.8 | -34.9 | 20.7 | 47.4 | 0.076 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -51.8 | -42.1 | 13.8 | 44.6 | -0.887 |
Provision for Income Taxes | |||||
Net Income After Taxes | -51.8 | -42.4 | 13.8 | 44.6 | -0.887 |
Net Income Before Extraordinary Items | |||||
Net Income | -51.8 | -42.4 | 13.8 | 44.6 | -0.887 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -51.8 | -42.4 | 13.8 | 44.6 | -0.887 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -6.33 | -4.95 | 1.45 | 4.33 | -0.086 |